Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Tech Stocks Rebound, Led by Microsoft’s Best Day Since 2008

Microsoft's stock jumped 15.5%, marking its best day since 2008, and drove a significant rebound in U.S. markets. The S&P 500 gained 1.7%, while the Dow Jones Industrial Average surged 613 points, or 1.2%. Investors responded positively to Microsoft’s stronger-than-expected quarterly profits and particularly …

Vinay Lochav | 03 August 2026

Elanco (NYSE:ELAN) Barely Moves Into Q2 Earnings, but the Animal-Health Turnaround Now Has Real Traction

Elanco Animal Health (NYSE:ELAN) closed at $26.37, down nine cents, or 0.34%, on volume of about 5.2 million shares. That is a shrug of a session, and an unusually calm one, given what happens next. The company reports second-quarter results on Wednesday, 5 August, …

Nitish Kishor | 03 August 2026

Tim Cook Claims Apple's Hybrid AI Strategy Is a Competitive Weapon

Apple's outgoing CEO Tim Cook characterized the company's hybridArtificial Intelligence (AI)strategy as a key competitive weapon, highlighting its significance as Apple prepares to monetarily integrate AI capabilities into iCloud services. This strategic positioning ahead of the upcoming Siri AI launch could enhance Apple's competitive …

Vinay Lochav | 03 August 2026

Eli Lilly (NYSE:LLY) Heads Into an August 5 Earnings Test With Its Obesity Pill Launch Under the Microscope

Lilly (NYSE:LLY) reports second-quarter 2026 results on August 5 and hosts a conference call at 10 a.m. Eastern. Investors already know roughly what the injectables will do. What they do not know is whether the company's oral GLP-1, Foundayo (orforglipron), is a slow starter …

Nitish Kishor | 03 August 2026

U.S.-China AI Leadership Gap Narrows, Calls for Strategy Overhaul

A growing perception suggests the United States is on the verge of losing its technological superiority in artificial intelligence to China. This shift comes amid increased scrutiny of U.S. capabilities in formulating a strategy that preserves its leading position. The implications for various sectors, …

Vinay Lochav | 03 August 2026

Exelixis (NASDAQ:EXEL) Falls 5.3% in a Biotech Sell-Off With Zanzalintinib's Verdict Still Ahead, Is the Drop Overdone?

Exelixis (Nasdaq:EXEL) closed at $53.03 at last closing, down $2.94 or 5.25%, on roughly 3.0 million shares against a recent daily average nearer two million. The size of the fall matches the move flagged in early commentary. Its cause does not match the usual …

Nitish Kishor | 03 August 2026

VASO Corp (OTC: VASO) Agrees to Sell NetWolves for $14.5M in Cash

VASO Corp (OTC: VASO) has entered into a definitive agreement to sell its subsidiary NetWolves Network Services for a total cash consideration of $14.5 million. This move comes as VASO seeks to streamline its operations and focus on enhancing its coreBusinessofferings. The sale marks …

Vinay Lochav | 03 August 2026

GE HealthCare (NASDAQ:GEHC) Retreats After a 12% Earnings Pop, but the AI-Imaging Premium Already Deflated

GE HealthCare (Nasdaq:GEHC) shares closed at $68.02 at last closing, down 2.75% on the day and 5.4% below the $71.90 close reached on 29 July, when second-quarter results lifted the stock 12.15% on volume of 15.3 million shares, several times its recent daily average. …

Nitish Kishor | 03 August 2026

Edwards Lifesciences (NYSE:EW) Beat and Raised on Double-Digit Growth, So Why Did the Stock Slip?

The second-quarter report Edwards Lifesciences (NYSE:EW) filed at last closing was, on its face, the cleanest print the structural heart company has produced in some time. Sales of $1.74 billion rose 13.6% as reported and 12.5% in constant currency against $1.53 billion a year …

Nitish Kishor | 03 August 2026
Support

Hi! How can we help you today?

Loading…